CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 180 filers reported holding CHEMOCENTRYX INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,247,000 | +346.6% | 62,848 | +114.1% | 0.01% | +350.0% |
| Q2 2022 | $727,000 | -53.0% | 29,349 | -52.4% | 0.00% | -60.0% |
| Q1 2022 | $1,546,000 | -62.0% | 61,701 | -44.8% | 0.01% | -61.5% |
| Q4 2021 | $4,070,000 | +667.9% | 111,788 | +260.6% | 0.01% | +550.0% |
| Q3 2021 | $530,000 | -10.9% | 31,000 | +222.9% | 0.00% | 0.0% |
| Q4 2020 | $595,000 | +91.9% | 9,600 | +69.6% | 0.00% | 0.0% |
| Q3 2020 | $310,000 | +50.5% | 5,662 | -61.7% | 0.00% | 0.0% |
| Q1 2019 | $206,000 | +5.1% | 14,800 | +2.8% | 0.00% | +100.0% |
| Q1 2018 | $196,000 | +256.4% | 14,400 | +144.1% | 0.00% | – |
| Q2 2017 | $55,000 | -28.6% | 5,900 | -44.3% | 0.00% | -100.0% |
| Q1 2017 | $77,000 | -75.9% | 10,600 | -75.5% | 0.00% | -50.0% |
| Q4 2016 | $320,000 | – | 43,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |